Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Fools Corner
  • Published:

Going short on biotech

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Notes

  1. * Nature Biotechnology does not guarantee the veracity, reliability, or completeness of any information provided on this page; it is not responsible for any errors or omissions or for any results obtained from the use of such information; it will not be liable for any loss, damage, or investment decision arising from a reader's reliance on the information provided.

Authors

Additional information

Tom Jacobs, of the Internet site Motley Fool (), provides his angle on biotechnology investments. Read on and become “Foolishly” informed * . He can be contacted about biotechnology and investing at . Jacobs cannot give individual investment advice but welcomes any.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jacobs, T. Going short on biotech. Nat Biotechnol 21, 1133 (2003). https://doi.org/10.1038/nbt1003-1133

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/nbt1003-1133

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing